| Active substance |
Furosemid |
| Also known as |
Frusemide (especially in some European countries) |
| Blood pressure |
Lowers blood pressure |
| Chemical name |
4-chloro-N-furfuryl-5-sulfamoylanthranilic acid |
| Dosage (medical) |
Typically, 20 to 80 mg per day, adjusted according to response |
| Dosage (sports) |
Not applicable as usage for performance enhancement is not recommended |
| Effects |
Increases urinary output, reduces blood pressure, decreases fluid retention |
| Formula |
C12H11ClN2O5S |
| Half-life |
Approximately 2 hours |
| Hepatotoxicity |
Low risk of hepatotoxicity |
| Lab Test |
Can be detected in urine tests |
| Main action |
Inhibits the Na-K-2Cl symporter in the thick ascending limb of the loop of Henle |
| Side effects |
Dehydration, hypokalemia, hyponatremia, hypovolemia, dizziness, hypotension |
| Storage conditions |
Store at room temperature, away from light and moisture |
| Substance class |
Loop diuretic |
| Trade name |
Lasix, among others |
| Use in sports |
Primarily as a masking agent to hide the presence of other banned substances |
| Water Retention |
Reduces water retention |
| Active ingredient, mg |
40 |
| Release form |
Pills |
| 1 Pill, mg |
40 |
| Blister, pills |
2, 10 |
| Manufacturer |
Sopharma |
| Packing |
Blister (10 Pills), Package (2 blisters) |
